Zenith Drugs (ZENITHDRUG)
STALWARTScore breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹44.2 |
| Market Cap | ₹84.89 Cr |
| P/E Ratio | 19.97 |
| ROCE | 12.9% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -55.24% |
| Debt/Equity | — |
| Sales Growth | 15.56% |
| Promoter Holding | 69.98% |
| 52-Week Range | ₹33.3 — ₹78.95 |
| Sector | Pharmaceuticals & Biotechnology |
Zenith Drugs trades with a P/E ratio of 19.97, ROCE of 12.9%, profit growth of -55.24%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer